Medicare Enrolled

Dr. Stacy Smith, M.D.

Neurology · Bellaire, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
4460 BISSONNET ST STE 200, Bellaire, TX 77401
7135243434
In practice since 2011 (14 years)
NPI: 1306138235 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Smith from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Smith? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Smith

Dr. Stacy Smith is a neurology in Bellaire, TX, with 14 years in practice. Based on federal Medicare data, Dr. Smith performed 8,921 Medicare services across 452 unique beneficiaries.

Between the years covered by Open Payments, Dr. Smith received a total of $205,518 from 62 pharmaceutical and/or device companies across 904 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Smith is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice▲ Top 9% volume in TX$ $205,518 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,921
Medicare services
Top 9% in TX for neurology
452
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~637 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit8,300$5$8
Office visit, established patient (30-39 min)169$85$236
Visual field test, extended133$47$224
Optic nerve imaging (OCT scan)84$28$58
New patient office visit, complex (60-74 min)72$158$450
Exam to measure eye deviation and range of motion46$46$163
Office visit, established patient, complex (40-54 min)41$124$316
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face37$106$300
Exam of visual field with limited testing27$25$150
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or12$25$97
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$205,518
Total received (2018-2024)
Avg $29,360/year across 7 years
Top 4% in TX for neurology
62
Companies
904
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$193,863 (94.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,976 (4.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,679 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,835
2023
$2,234
2022
$32,490
2021
$24,310
2020
$78,515
2019
$42,450
2018
$13,684

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$80,939
Lilly USA, LLC
$66,720
Biohaven Pharmaceutical Holding Company Ltd.
$17,613
Allergan, Inc.
$12,274
PFIZER INC.
$8,869
AbbVie Inc.
$8,563
ABBVIE INC.
$1,932
Allergan Inc.
$982
Amgen Inc.
$825
UCB, Inc.
$734
Novartis Pharmaceuticals Corporation
$586
AstraZeneca Pharmaceuticals LP
$572
Eisai Inc.
$439
Biohaven Pharmaceuticals, Inc.
$439
Neurocrine Biosciences, Inc.
$407
Alexion Pharmaceuticals, Inc.
$333
SK Life Science, Inc.
$243
Biogen, Inc.
$206
Grifols USA, LLC
$202
Takeda Pharmaceuticals U.S.A., Inc.
$191
Eli Lilly and Company
$174
Sunovion Pharmaceuticals Inc.
$152
Genentech USA, Inc.
$149
Adamas Pharmaceuticals, Inc.
$141
Boston Scientific Corporation
$119
Amneal Pharmaceuticals LLC
$116
ARGENX US, INC.
$113
Supernus Pharmaceuticals, Inc.
$109
Promius Pharma LLC
$92
GENZYME CORPORATION
$85
Penumbra, Inc.
$74
Medtronic, Inc.
$73
Lundbeck LLC
$70
Upsher-Smith Laboratories LLC
$69
Horizon Therapeutics plc
$67
EISAI INC.
$61
ACADIA Pharmaceuticals Inc
$58
Abbott Laboratories
$58
Averitas Pharma Inc.
$57
Merz North America, Inc.
$56
EMD Serono, Inc.
$54
Janssen Pharmaceuticals, Inc
$41
IMPEL PHARMACEUTICALS INC.
$41
TG Therapeutics, Inc.
$35
Acorda Therapeutics, Inc
$31
Zyla Life Sciences, Inc.
$31
Sumitomo Pharma America, Inc.
$30
GRT US Holding, Inc.
$30
Zyla Life Sciences
$29
Alnylam Pharmaceuticals Inc.
$28
UPSHER-SMITH LABORATORIES LLC
$27
Bausch Health US, LLC
$23
LivaNova USA, Inc.
$23
Collegium Pharmaceutical, Inc.
$20
Assertio Therapeutics, Inc.
$17
Nevro Corp.
$17
Harmony Biosciences LLC
$15
Life Molecular Imaging Ltd
$15
ARBOR PHARMACEUTICALS, INC.
$14
Axsome Therapeutics, Inc.
$13
HARMONY BIOSCIENCES LLC
$13
Retrophin, Inc.
$10
Top 3 companies account for 80.4% of total payments
Associated products mentioned in payments ›
(820) Cholbam · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Actemra · Activase · Aimovig · Austedo XR · BOTOX · BRILINTA · BRIUMVI · Briviact · CAMBIA · COPAXONE · EMGALITY · Fintepla · Fycompa · GAMMAGARD · GOCOVRI · Gamunex-C · HYQVIA · Horizant · INFINITY · INGREZZA · KESIMPTA · Leqembi · MAVENCLAD · MIGRANAL · NEURACEQ · NUPLAZID · NURTEC ODT · Nayzilam · OCREVUS · ONPATTRO · Ocrevus · Ongentys · Penumbra Coil 400 · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · REYVOW · RYTARY · Repatha · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Senza · Soliris · Sunosi · TECFIDERA · TEPEZZA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · V-LOC 180 · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · Wakix · XARELTO · XEOMIN · XTAMPZA · ZAVZPRET · ZEMBRACE SYMTOUCH · ZOMIG · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in TX.

Equivalent to $2,304 per 100 Medicare services performed
Looking for a neurology in Bellaire?
Compare neurologys in the Bellaire area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
387
Per 100K population
8.1
County median income
$73,104
Nearest hospital
BEHAVIORAL HOSPITAL OF BELLAIRE
1.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Smith is a mixed practice specialist, with above-average Medicare volume (top 9% in TX), and high industry engagement (speaking/promotional, top 4%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Smith experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Smith performed 8,300 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Smith receive payments from pharmaceutical companies?
Yes. Dr. Smith received a total of $205,518 from 62 companies across 904 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Smith's costs compare to other neurologys in Bellaire?
Dr. Smith's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Smith) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →